Maria-Jacqueline Barona-Acevedo

Prof. Dr. Maria-Jacqueline Barona-Acevedo

University of Antioquia, Medellín, Antioquia, Colombia
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in The Journal of Nutrition
Verified
Journal Article
Open access
PDF file
MBMaria-Jacqueline Barona-Acevedo
Maria-Jacqueline Barona-Acevedo
JAJuan Aristizabal
Juan Aristizabal
CBChristopher N. Blesso
Christopher N. Blesso
JVJeff S. Volek
Jeff S. Volek
MFMaria Luz Fernandez
Maria Luz Fernandez
We evaluated the effects of grape polyphenols in individuals classified with metabolic syndrome (MetS). Men (n = 24) aged 30–70 y were randomly assig

1 March 2013 in Metabolism
Verified
Journal Article
Closed access
CBChristopher N. Blesso
Christopher N. Blesso
Catherine J. AndersenCatherine J. Andersen
Catherine J. Andersen
MBMaria-Jacqueline Barona-Acevedo
Maria-Jacqueline Barona-Acevedo
JVJeff S. Volek
Jeff S. Volek
Maria-Luz FernandezMaria-Luz Fernandez
Maria-Luz Fernandez

15 March 2013 in Lipids
Verified
Journal Article
Closed access
PDF file
Catherine J. AndersenCatherine J. Andersen
Catherine J. Andersen
CBChristopher N. Blesso
Christopher N. Blesso
JLJiyoung Lee
Jiyoung Lee
MBMaria-Jacqueline Barona-Acevedo
Maria-Jacqueline Barona-Acevedo
DSDharika Shah
Dharika Shah
Maria-Luz FernandezMaria-Luz Fernandez
Maria-Luz Fernandez

1 January 2006 in Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
Verified
Journal Article
Closed access
MBMaria-Jacqueline Barona-Acevedo
Maria-Jacqueline Barona-Acevedo
CBCesar V.F. Batista
Cesar V.F. Batista
FZFernando Z. Zamudio
Fernando Z. Zamudio
FGFroylan Gomez-Lagunas
Froylan Gomez-Lagunas
EWEnzo Wanke
Enzo Wanke
LPLourival D. Possani
Lourival D. Possani

1 September 2013 in Journal of Clinical Lipidology
Verified
Journal Article
Closed access
CBChristopher N. Blesso
Christopher N. Blesso
Catherine J. AndersenCatherine J. Andersen
Catherine J. Andersen
MBMaria-Jacqueline Barona-Acevedo
Maria-Jacqueline Barona-Acevedo
BVBrittanie Volk
Brittanie Volk
JVJeff S. Volek
Jeff S. Volek
MFMaria Luz Fernandez
Maria Luz Fernandez

1 December 2006 in Transactions of the Royal Society of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
RORafael Otero
Rafael Otero
GLGuillermo León
Guillermo León
José María GutiérrezJosé María Gutiérrez
José María Gutiérrez
GRGustavo Rojas
Gustavo Rojas
MTMaría Fabiola Toro
María Fabiola Toro
RTR. David G. Theakston
R. David G. Theakston
The efficacy and safety of two whole IgG polyvalent antivenoms (A and B) were compared in a randomised, blinded clinical trial in 67 patients systemically envenomed by Bothrops asper in Colombia. Both antivenoms were fractionated by caprylic acid precipitation and had similar neutralising potencies, protein concentrations and aggregate contents. Antivenom B was additionally treated with beta-propiolactone to lower its anticomplementary activity. Analysing all treatment regimens together, there were no significant differences between the two antivenoms (A=34 patients; B=33 patients) in the time taken to reverse venom-induced bleeding and coagulopathy, to restore physiological fibrinogen concentrations and to clear serum venom antigenaemia. Blood coagulability was restored within 6-24 h in 97% of patients, all of whom had normal coagulation and plasma fibrinogen levels 48 h after the start of antivenom treatment. Two patients (3.0%) had recurrent coagulopathy and eight patients suffered recurrence of antigenaemia within 72 h of treatment. None of the dosage regimens of either antivenom used guaranteed resolution of venom-induced coagulopathy within 6 h, nor did they prevent recurrences. A further dose of antivenom at 6 h also did not guarantee resolution of coagulopathy within 12-24 h in all patients. The incidence of early adverse reactions (all mild) was similar for both antivenoms (15% and 24%; P>0.05).